Japan
/
Food
/
TSE:2206

Ezaki Glico Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St

February 17, 2025

Ezaki Glico (TSE:2206) Full Year 2024 Results

Key Financial Results

Revenue: JP¥331.1b (flat on FY 2023).
Net income: JP¥8.11b (down 43% from FY 2023).
Profit margin: 2.5% (down from 4.2% in FY 2023).
EPS: JP¥128 (down from JP¥222 in FY 2023).

revenue-and-expenses-breakdown — TSE:2206 Revenue and Expenses Breakdown February 17th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ezaki Glico Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 18%.

The primary driver behind last 12 months revenue was the Overseas Business segment contributing a total revenue of JP¥82.3b (25% of total revenue). Notably, cost of sales worth JP¥203.5b amounted to 61% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to JP¥55.8b (47% of total expenses). Explore how 2206's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Food industry in Japan.

Performance of the Japanese Food industry.

The company's shares are down 2.2% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Ezaki Glico.

Valuation is complex, but we're here to simplify it.

Discover if Ezaki Glico might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.